Velpatasvir
Chemical Structure Depiction of
Velpatasvir
Velpatasvir
Compound characteristics
| Compound ID: | CE03-7675 |
| Compound Name: | Velpatasvir |
| Molecular Weight: | 883.02 |
| Molecular Formula: | C49 H54 N8 O8 |
| CAS Number: | 1377049-84-7 |
| Smiles: | CC(C)[C@@H](C(N1[C@@H](C)CC[C@H]1c1nc2ccc3cc4c5ccc(cc5COc4cc3c2[nH]1)c1cnc([C@@H]2C[C@@H](CN2C([C@@H](c2ccccc2)NC(=O)OC)=O)COC)[nH]1)=O)NC(=O)OC |
| InChI Key: | FHCUMDQMBHQXKK-QMGZAXQBSA-N |
| Short Description: | Velpatasvir (GS-5816), also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor. GS-5816 has demonstrated pan-genotypic activity and a high barrier to resistance in HCV replic on assays. GS-5816 demonstrated pangenotypic antiviral activity in patients with genotype 1-4 HCV infection. It will be further evaluated in combination with other pangenotypic direct-acting antiviral s to achieve the goal of developing a well-tolerated, highly effective treatment for all HCV genotypes. |
| Pathway: | Microbiology/Virology|||Proteases/Proteasome |
| Target: | HCV Protease|||SARS-CoV |
| Type of molecule: | FDA Approved/Clinical |
| Alias: | GS-5816 |
| Stock amount: | 3074 |